CVS Health said on Friday it has cut bonuses for some employees because of its low profit levels last year, as the healthcare ...

CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

Companies are telling their investors how President Donald Trump’s plan to radically remake the US government poses new risks ...

For the second year running, nonprofit consulting firm Good Energy applied its Climate Reality Check to the actual ...

Valentina Dabos, lead author of the tracker, said in a statement that the consequences of bankruptcies in healthcare "can be ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...